This is a snippet of the transcript, sign up to read more.
What really helped them was Walmart. When Walmart was building their stores and warehouses, they required floors with a certain levelness and flatness, specifying the use of a laser screed in their agreements. Walmart's adoption of the technology accelerated the business's growth. Towards the latter part of the 90s, Paul and Dave decided they didn't want to run the business. They enjoyed creating something but weren't interested in managing it, as they were contractors at heart. They sold the business to a private equity firm to exit and monetize their investment, fully stepping away from day-to-day operations.
This is a snippet of the transcript, sign up to read more.
For large projects, which I define as more than 20,000 square feet, in mature markets like Europe, Australia, and the US, a laser screed is used in the high 90s percentage of cases. For smaller footprint buildings, it's not 100%, but it's still the majority, maybe two-thirds or 75%. So, growth in developed markets for laser screeds is limited. I don't have an exact number for it.
This is a snippet of the transcript, sign up to read more.
A lot of attention was paid to increasing the addressable market through adjacent products, not necessarily laser screeds, but similar products. For example, the Line Dragon, which is a concrete hose pulling and placing solution, automates the process of moving concrete hoses around the job site with remote-controlled equipment. This created a new market. We bought a small company with a similar product and combined it. This is currently generating about $3 to $4 million in revenue. Other products like the Broom + Cure, which is a finishing product for external slabs, were added to the portfolio. These are $4 to $5 million products that help increase the products we can sell to our customer base. However, there's a limitation on how much more you can sell to core customers, so you need to target different market segments.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research